Results 81 to 90 of about 29,009 (218)

Effectiveness of 5% Topical Imiquimod for Lentigo Maligna Treatment

open access: yesActa Dermato-Venereologica, 2019
Lentigo maligna (LM) is treated to prevent progression to lentigo maligna melanoma (LMM). Surgery is the gold standard but an alternative treatment is off-label topical imiquimod.
Darryl C.K.S. Tio   +4 more
doaj   +1 more source

Dermoscopic Ulceration is a Predictor of Basal Cell Carcinoma Response to Imiquimod: A Retrospective Study [PDF]

open access: yes, 2017
Imiquimod is considered one of the treatments of choice for low-risk superficial basal cell carcinoma (sBCC) and an alternative option for non-superficial tumours when surgery is contraindicated or not feasible (1\u20133).
Alfano, Roberto   +8 more
core   +2 more sources

Practice Patterns in Extramammary Paget's Disease

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background In patients with Extramammary Paget's Disease (EMPD), a rare intraepithelial adenocarcinoma, wide local excision (WLE) has historically been the standard of treatment despite high rates of positive margins and recurrence. Mohs micrographic surgery (MMS) has demonstrated superior outcomes, yet practice patterns vary due to limited ...
Yasmine Mohseni   +4 more
wiley   +1 more source

A zebrafish and mouse model for selective pruritus via direct activation of TRPA1

open access: yeseLife, 2018
Little is known about the capacity of lower vertebrates to experience itch. A screen of itch-inducing compounds (pruritogens) in zebrafish larvae yielded a single pruritogen, the TLR7 agonist imiquimod, that elicited a somatosensory neuron response ...
Kali Esancy   +5 more
doaj   +1 more source

Conventional and combination topical photodynamic therapy for basal cell carcinoma:systematic review and meta-analysis [PDF]

open access: yes, 2018
Topical photodynamic therapy (PDT) is an established treatment option for low-risk basal cell carcinoma (BCC).To compare efficacy, cosmesis and tolerability of PDT for BCC with alternative treatments.MEDLINE, PubMed, Embase and CENTRAL databases were ...
Arits   +45 more
core   +3 more sources

Medication prescription patterns in cancer rehabilitation physiatry outpatients: A multicenter retrospective study

open access: yesPM&R, EarlyView.
Abstract Background and Objective Previous work from this dataset found 45% prescribing frequency of any medications (35.1%, 33.5%, and 56.8% at institutions 1, 2, and 3 respectively), without significant difference between in‐person and telemedicine.
Matthew Chen   +7 more
wiley   +1 more source

Imiquimod for the treatment of genital warts: a quantitative systematic review

open access: yesBMC Infectious Diseases, 2001
Objective To review published randomised controlled trials to assess the benefit and harm of imiquimod in the treatment of external genital warts. Data sources MEDLINE (1966 - December 2000), Cochrane Library (Issue 3, 2000) and PubMed (December 15, 2000)
Hopwood Jennie   +3 more
doaj   +1 more source

PSS5 RESTOR® VERSUS ACRILISA® : ND-YAG LASER INCIDENCE RATE COMPARISON 18 MONTHS AFTER SURGERY [PDF]

open access: yes, 1948
Digitalitzat per ...
Gauthier, L   +3 more
core   +1 more source

Harnessing Natural Compounds in Psoriasis: Targeting Cellular Pathways for Effective Therapy

open access: yesPhytotherapy Research, EarlyView.
Natural compounds act on key cellular pathways in psoriasis by suppressing keratinocyte hyperproliferation, modulating Th17/IL‐17‐mediated immune responses, and reducing oxidative stress. These multi‐target effects highlight their potential as safer adjunctive therapies alongside conventional treatments.
Hye Jin Lee   +9 more
wiley   +1 more source

Macrophage autophagy in atherosclerosis [PDF]

open access: yes, 2013
Macrophages play crucial roles in atherosclerotic immune responses. Recent investigation into macrophage autophagy (AP) in atherosclerosis has demonstrated a novel pathway through which these cells contribute to vascular inflammation.
Carnuccio, R.   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy